PRIMARY STUDY

Diagnosis, causes, and treatment of dyspareunia in postmenopausal women

Key Findings:  This analysis of postmenopausal dyspareunia discusses several causes of, and muultiple treatment options that are being considered, including lubricants, moisturizers, vaginal estrogen, ospemifene, dehydroepiandrosterone, local testosterone therapy, cannabidiol, and fractional CO 2 laser treatments.

Type of Study:  Meta-analysis

Study Result:  Positive

Research Location(s):  United States

Year of Pub:  2023


Cannabinoids Studied:  Cannabidiol (CBD), Pharma CBD

Phytocannabinoid Source:  Not Applicable

Chemotype:  Chemotype III

Ligands Studied:  Estrogen

Route of Administration:  Topical




Citation:  Streicher LF. Diagnosis, causes, and treatment of dyspareunia in postmenopausal women. Menopause. 2023 Jun 1;30(6):635-649. doi: 10.1097/GME.0000000000002179. Epub 2023 Apr 11. PMID: 37040586.